Kinesiotaping in Knee Osteoarthritis

April 23, 2022 updated by: Şeniz Akçay, Bozyaka Training and Research Hospital

Does Kinesiotaping Effective for Knee Osteoarthritis? Randomized Controlled Trial

Kinesiotape is one of the treatment choices for the patients with knee osteoarthritis. Unlike the brace, it seems to be an important advantage in kinesiotape application in that it permits the movement of the joint. However, kinesiotape is conditionally recommended for knee osteoarthritis in the 2019 American College of Rheumatology treatment recommendations due to limiting the quality of evidence, using various application methods, and the lack of blindness concerning its use is not possible.

The aim of the study is to determine the effects of kinesiotaping on pain, physical performance, knee range of motion, and postural stability in knee osteoarthritis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Non-pharmacological treatments are recommended as first-line management in knee osteoarthritis. Kinesiotape was regarded as a supplementary intervention for patients with knee osteoarthritis. Although the results are conflicting, regarding knee osteoarthritis, recently published studies indicate beneficial effects of kinesiotape on knee-related health status, pain, quadriceps muscle strength, and range of motion. On the other hand, the measurements were performed immediately following taping or within a short-term period. The inconsistency of the study data still indicates that the efficacy of kinesiotape in knee osteoarthritis should be evaluated in randomized controlled trials. Therefore a study that investigates both short and long-term follow-up results are warranted.

This study aimed to determine the immediate and long-term effects of the single and repetitive application of kinesiotape on pain, knee joint range of motion, postural stability, and physical performance in participants with knee osteoarthritis. The results of this study will support evidence-based reports based on the effectiveness of kinesiotape in knee osteoarthritis and recommendations for future studies.

Study Type

Interventional

Enrollment (Actual)

57

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • İzmir, Turkey
        • University of Health Sciences Izmir Bozyaka Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pain for a minimum of 3 months
  • Pain intensity within the last week minimum of 3 according to the visual analogue scale (VAS) at the symptomatic knee
  • Grade 2-3 knee OA according to the Kellgren and Lawrence Scale
  • Ability to perform the tests

Exclusion Criteria:

  • Fragile, very sensitive skin, or lesions in the area
  • Inflammatory arthritis
  • Inability to perform functional tests
  • Pregnancy
  • Use of drugs associated with a psychiatric disorder
  • Previous joint replacement surgery for knee/hip joints
  • Diagnosis with balance disorder
  • Disorders that may cause loss of muscle strength in the lower extremities
  • Previous experience with the Kinesiotaping method

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Kinesiotape
The participants received kinesiotape to the rectus femoris muscle.
Device: Kinesiotape
The participants received kinesiotape application three times with one-week intervals. Y strip tape was used. The interventionist applied the band to the rectus femoris muscle with facilitation technique.
Other: Home-based exercise program
Participants were taught exercise program training. The exercise intervention was based on quadriceps and knee flexor muscle group strengthening, and knee joint range of motion exercises, in their home.
Sham Comparator: Sham-kinesiotape
Non-specific taping was applied.
Other: Home-based exercise program
Participants were taught exercise program training. The exercise intervention was based on quadriceps and knee flexor muscle group strengthening, and knee joint range of motion exercises, in their home.
Device: Sham-kinesiotape

The participants received sham-kinesiotape application three times with one-week intervals.

In the sham group, the interventionist adhered KT to the rectus femoris transversely, without stretching.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Pain intensity-rest at 1st hour, 3rd week, and 7th week
Time Frame: Baseline (week 0), 1st hour, 3rd week, 7th week
Pain intensity was assessed by using the Visual Analogue Scale (VAS). Each patient was asked to indicate pain intensity during rest at each assessment point (on a 0-10 points numerical pain rating scale; higher scores indicate severe pain).
Baseline (week 0), 1st hour, 3rd week, 7th week
Change from Baseline Pain intensity-activity at 1st hour, 3rd week, and 7th week
Time Frame: Baseline (week 0), 1st hour, 3rd week , 7th week
Pain intensity was assessed by using the Visual Analogue Scale (VAS). Each patient was asked to indicate pain intensity during 50-meter walking test at each assessment point (on a 0-10 points numerical pain rating scale; higher scores indicate severe pain).
Baseline (week 0), 1st hour, 3rd week , 7th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Knee-Related Health Status at 1st hour, 3rd week, and 7th week
Time Frame: Baseline (week 0), 1st hour, 3rd week , 7th week
To determine the baseline and the degree of change in knee-related health status Western Ontario and McMaster Universities Osteoarthritis Index was applied. Western Ontario and McMaster Universities Osteoarthritis Index, is a widely valid and reliable outcome measurement scale in patients with knee osteoarthritis. The scale consists of 24 items and is divided into three dimensions; pain; stiffness, and functionality.
Baseline (week 0), 1st hour, 3rd week , 7th week
Change from Baseline Pain-free Knee Range of Motion at 1st hour, 3rd week, and 7th week
Time Frame: Baseline (week 0), 1st hour, 3rd week , 7th week
Active pain-free knee range of motion examination was performed by a 360̊ double-armed universal goniometer. Knee active flexion range of motion angle without pain was measured in the supine position while the axis of the goniometer was on the femur's lateral epicondyle. For active knee extension range of motion, the investigator recorded the angle that which the participant extends the knee as much as possible. If there was an inability to reach the 0-degree starting position, the angle was given a negative value reflecting the angle missing from the full extension. Three assessment was performed and the mean value was recorded as active flexion and extension angle.
Baseline (week 0), 1st hour, 3rd week , 7th week
Change from Baseline Physical Function at 1st hour, 3rd week, and 7th week
Time Frame: Baseline (week 0), 1st hour, 3rd week , 7th week

The physical function of the participants enrolled in the study was evaluated by the 50-meter walking test will the subjects walk 2.5 return journeys between two cones placed 10 m apart along a walking course. The participants stood beside the cone. They were instructed to walk to the other when signaled by the investigator, go around it to the outer side, and walk back again as fast as possible.

The time taken the task completed assessed by the same chronometer was recorded
Baseline (week 0), 1st hour, 3rd week , 7th week
Change from Baseline Static Postural Stability at 1st hour, 3rd week, and 7th week
Time Frame: Baseline (week 0), 1st hour, 3rd week , 7th week
The quantitative measure of the balance and postural stability of participants was performed by the Biodex Balance System (BBS). Participants completed three trial repetitions before static balance tests. For the static balance test, the participants were asked to stand with two legs on the center of the locked platform of the BBS. Three evaluations were performed in each measurement session and a mean score was calculated from the three trials. The device provides three postural stability indices (PSI) obtained by calculating the standard deviations of the degrees of an inclination concerning the zero point: overall static postural stability index (sPSI_O), static anteroposterior postural stability index (sPSI_AP), and static mediolateral postural stability index (sPSI_ML).
Baseline (week 0), 1st hour, 3rd week , 7th week
Change from Baseline Dynamic Postural Stability at 1st hour, 3rd week, and 7th week
Time Frame: Baseline (week 0), 1st hour, 3rd week , 7th week

The quantitative measure of the balance and postural stability of participants was performed by the Biodex Balance System (BBS). Participants completed three trial repetitions before dynamic balance tests.

During the dynamic balance test, the platform moves simultaneously to the anteroposterior (AP), or mediolateral (ML) directions in 12 different stability levels (level 1 is the least stable; level 12 is the most stable level within a 20-degree range of inclination). Dynamic PSI (dPSI) represents the variance of foot platform displacement in degrees, from level, in all motions during the test. A high number is indicative of a lot of movement during the test. Dynamic balance test was performed on the most stable level with the following parameters: duration: 20 seconds, stability level: 12, and stance: two legs
Baseline (week 0), 1st hour, 3rd week , 7th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bozyaka Training and Research Hospital

Investigators

  • Principal Investigator: Nesibe Doğan, MD, University of Health Sciences Izmir Bozyaka Training and Research Hospital
  • Study Chair: Hayriye Yılmaz, MSc, PT, University of Health Sciences Izmir Bozyaka Training and Research Hospital
  • Study Chair: Buğra İnce, MD, University of Health Sciences Izmir Bozyaka Training and Research Hospital
  • Study Director: Şeniz Akçay, Assoc. Prof., University of Health Sciences Izmir Bozyaka Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2019

Primary Completion (Actual)

October 26, 2021

Study Completion (Actual)

October 26, 2021

Study Registration Dates

First Submitted

April 18, 2022

First Submitted That Met QC Criteria

April 23, 2022

First Posted (Actual)

April 28, 2022

Study Record Updates

Last Update Posted (Actual)

April 28, 2022

Last Update Submitted That Met QC Criteria

April 23, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 11/09/2019-06

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on Kinesiotape

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe